** Shares of medical device maker Kestra Medical Technologies KMTS.O slide ~10.6% to $24.12

** KMTS announces public offering of 5.5 million shares

** BofA Securities, Piper Sandler, J.P. Morgan, Goldman Sachs and Wells Fargo Securities are acting as bookrunners for offering

** Capital raise comes just months after KMTS went public in New York following an upsized $202 million IPO

** Meanwhile, KMTS expects Q2 2026 revenue between $22.2 million and $22.6 million, compared with $14.7 million a year earlier

** Loss from operations expected between $31.6 million and $32 million, compared with $19.1 million a year earlier

** KMTS had ~51.3 million outstanding shares as of July 31, per offering prospectus

** As of last close, KMTS stock up 58.7% since debut in March

(Reporting by Arasu Kannagi Basil in Bengaluru)

((ArasuKannagi.Basil@thomsonreuters.com))